Private providers of NHS services

Intraoperative Imaging Market worth $2.5 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, February 23, 2021

Demand for intraoperative imaging from key end-users has declined a bit amidst the global COVID-19 pandemic.

Key Points: 
  • Demand for intraoperative imaging from key end-users has declined a bit amidst the global COVID-19 pandemic.
  • Mobile C-arms are medical imaging devices that comprise a generator, the X-ray source, and an image intensifier or flat-panel detector.
  • Asia Pacific likely to emerge as the fastest growing intraoperative imaging market, globally
    Geographically, the emerging Asian countries, such as China, India, South Korea, Taiwan, and Singapore, are offering high-growth opportunities for market players.
  • Prominent players in this market General Electric Company (US), Siemens Healthineers AG (Germany), Ziehm Imaging GmbH (Germany), Medtronic (Ireland), and Koninklijke Philips N.V. (Netherlands) were the top five players in the global intraoperative imaging market.

DGAP-News: Fresenius Medical Care AG & Co. KGaA achieves 2020 targets, expects significant COVID-19 impact in 2021 and confirms 2025 outlook

Retrieved on: 
Tuesday, February 23, 2021

In 2020, Fresenius Medical Care provided more than 14% of its dialysis treatments in the U.S. in a home setting.

Key Points: 
  • In 2020, Fresenius Medical Care provided more than 14% of its dialysis treatments in the U.S. in a home setting.
  • This additionally affects the utilization of Fresenius Medical Care's clinic network and thereby limits the ability to mitigate fixed cost and wage inflation.
  • Fresenius Medical Care confirms its 2025 targets that are based on the Company's mid-term strategy.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Serco Announces Agreement to Acquire WBB, Strengthening Presence in High-End Consulting Services to Defense Markets

Retrieved on: 
Tuesday, February 16, 2021

WBB has around 1,000 employees, including more than 200 subject matter experts (SMEs) with experience in their respective technical disciplines.

Key Points: 
  • WBB has around 1,000 employees, including more than 200 subject matter experts (SMEs) with experience in their respective technical disciplines.
  • The deal will bolster Serco's existing capabilities in advanced areas, including Artificial Intelligence, machine learning, data analytics, and cyber consulting.
  • "Serco has enjoyed a relationship with WBB for many years working side by side on numerous defense programs.
  • Serco Inc. is a wholly-owned subsidiary of Serco Group plc, a $5 billion international business that helps transform government and public services around the world.

ACADIA HEALTHCARE ANNOUNCES DATE FOR FOURTH QUARTER AND YEAR-END 2020 EARNINGS RELEASE

Retrieved on: 
Wednesday, February 10, 2021

Franklin, Tenn., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its fourth quarter and year-end 2020 results on Thursday, February 25, 2021, after the close of the market.

Key Points: 
  • Franklin, Tenn., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its fourth quarter and year-end 2020 results on Thursday, February 25, 2021, after the close of the market.
  • Acadia will conduct a conference call with institutional investors and analysts at 10:00a.m.
  • Acadia is a leading provider of behavioral healthcare services across the United States.
  • Acadia operates a network of 227 behavioral healthcare facilities with approximately 9,900 beds in 40 states and Puerto Rico.

Cove Capital Acquires Fresenius Medical Care Dialysis Facility in New Orleans

Retrieved on: 
Thursday, February 4, 2021

LOS ANGELES, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Cove Capital Investments, LLC (Cove Capital) and its affiliates are pleased to announce the acquisition of the Fresenius Medical Care dialysis facility located at 704 Belle Terre Blvd., LaPlace, Louisiana 70068 (the Property).

Key Points: 
  • LOS ANGELES, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Cove Capital Investments, LLC (Cove Capital) and its affiliates are pleased to announce the acquisition of the Fresenius Medical Care dialysis facility located at 704 Belle Terre Blvd., LaPlace, Louisiana 70068 (the Property).
  • Specifically, the Property constitutes the single asset in Cove Capitals latest medical net-lease investment offering: Cove LaPlace Dialysis 26 DST, a regulation D, Rule 506c private placement.
  • As Cove Capital continues to grow, the company remains unrelenting in its dedication to providing 1031 investors with an assortment of quality net-leased properties with what we believe to be strong and enduring tenants, including tenants in the medical industry such as Fresenius Medical Care.
  • Accordingly, the Property, and its accompanying offering, represent the latest endeavor of Cove Capital into the medical net-lease offering space and serve to grow the ever-expanding line of DST offerings Cove Capital offers to investors.

United Kingdom NHS & Non-NHS Healthcare Markets Service with Digital Archive - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 4, 2021

The "Healthcare Markets (with digital archive)" newsletter has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Healthcare Markets (with digital archive)" newsletter has been added to ResearchAndMarkets.com's offering.
  • Healthcare Markets delivers comprehensive, reliable and independent reporting on the full range of acute and primary healthcare services markets operating outside, and in partnership with, the NHS.
  • The journal covers medical and surgical hospitals and clinics, psychiatric hospitals, dentistry, primary healthcare and temporary/flexible staffing.
  • The publisher is the chosen provider of independent sector healthcare market data to the UK government's Office for National Statistics.

DGAP-News: Fresenius Medical Care AG & Co. KGaA anticipates significant negative impact on 2021 net income from accelerated COVID-19 related excess mortality of dialysis patients; confirms mid-term targets

Retrieved on: 
Monday, February 1, 2021

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Forecast

Key Points: 
  • DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Forecast
    Fresenius Medical Care AG & Co. KGaA anticipates significant negative impact on 2021 net income from accelerated COVID-19 related excess mortality of dialysis patients; confirms mid-term targets
    The issuer is solely responsible for the content of this announcement.
  • Despite those negative impacts of the COVID-19 pandemic, Fresenius Medical Care has achieved - based on the preliminary and unaudited financials - its revenue target and slightly exceeded its net income [1] targets for 2020 [2] .
  • Through its network of 4,073 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 349,167 patients around the globe.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius Medical Care North America Enhances Nationwide Distribution of Home Dialysis Machines and Supplies with Descartes Last Mile Delivery Solution

Retrieved on: 
Monday, February 1, 2021

Descartes last mile delivery solution provides an end-to-end platform for home and last mile delivery operations.

Key Points: 
  • Descartes last mile delivery solution provides an end-to-end platform for home and last mile delivery operations.
  • Using advanced continuous optimization technology, Descartes last mile delivery solution takes committed appointments and improves route productivity, which generates additional delivery capacity and reduces costs.
  • Were pleased to help Fresenius Medical Care North America make the distribution of its services and equipment more responsive and efficient, said James Wee, Vice President at Descartes.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.

Presto-X Announces Rebrand To Rentokil In Dallas And Fort Worth

Retrieved on: 
Friday, January 29, 2021

DALLAS, Jan. 29, 2021 /PRNewswire/ --Presto-X announced a transition to the Rentokil brand in the Dallas and Fort Worth markets.

Key Points: 
  • DALLAS, Jan. 29, 2021 /PRNewswire/ --Presto-X announced a transition to the Rentokil brand in the Dallas and Fort Worth markets.
  • "Presto-X has been part of the Rentokil family since 2007, and we are excited to bring the resources and knowledge of the world's largest pest control provider, Rentokil, to our customers in the Dallas and Fort Worth communities.
  • For additional information on Rentokil and the pest control services in Dallas and Fort Worth, please visit: dallas.rentokil.com ,
    For nearly a century, customers have trusted Rentokil to protect their families, homes and businesses from pests and the health threats and damages they can cause.
  • Rentokil is part of Rentokil North America, which provides commercial and residential pest control to customers in the U.S., Canada and Puerto Rico.

Western Exterminator Announces Rebrand To Rentokil In Las Vegas

Retrieved on: 
Thursday, January 28, 2021

LAS VEGAS, Jan. 28, 2021 /PRNewswire/ --Western Exterminator announced a transition to the Rentokil brand in the Las Vegas market.

Key Points: 
  • LAS VEGAS, Jan. 28, 2021 /PRNewswire/ --Western Exterminator announced a transition to the Rentokil brand in the Las Vegas market.
  • "Western Exterminator has been part of the Rentokil family since 2012, and we are excited to bring the resources and knowledge of the world's largest pest control provider, Rentokil, to our customers in the Las Vegas community.
  • For additional information on Rentokil and the pest control services in Las Vegas, please visit: lasvegas.rentokil.com .
  • Rentokil is part of Rentokil North America, which provides commercial and residential pest control to customers in the U.S., Canada and Puerto Rico.